Approved for HEPCLUDEX is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or with compensated cirrhosis. This indication is approved under accelerated approval based on a decrease in HDV RNA and ALT normalization. Continued approval may be contingent upon verification of clinical benefit in a confirmatory trial.. HEPCLUDEX is an antiviral…
Loading full data from Know Your Drugs Institute…